2.32% -5.46

Ligand Pharmaceuticals Inc (LGND)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit Dividendenhistorie

Finanzdaten der Ligand Pharmaceuticals Inc-Aktie (LGND)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	48.32% 59.67	115.46	47.63	45.33	42.81
Operating Expenses	24.30% 45.82	60.53	39.18	81.55	52.45
Benefits Costs and Expenses	111.24% 2.886	-25.68	36.40	95.51	82.01
Costs And Expenses	111.24% 2.886	-25.68	36.40	95.51	82.01
Operating Income/Loss	74.80% 13.84	54.93	8.444	-36.22	-9.637
Nonoperating Income/Loss	50.19% 42.94	86.21	2.779	-13.96	-29.56
Income/Loss From Equity Method Investments	-	-	-	-	-1.245
Income/Loss From Continuing Operations Before Tax	59.77% 56.78	141.14	11.22	-50.18	-39.20
Income Tax Expense/Benefit	49.73% 12.00	23.86	6.376	-7.729	-8.112
Income/Loss From Continuing Operations After Tax	61.81% 44.78	117.27	4.847	-42.45	-31.09
Net Income/Loss	61.81% 44.78	117.27	4.847	-42.45	-31.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	100.15% -0.029	19.58	19.33	19.19	0.229
Diluted Average Shares	99.40% 0.124	20.63	19.93	19.19	-0.284
Basic Earnings Per Share	61.10% 2.33	5.99	0.25	-2.21	-1.72
Diluted Earnings Per Share	61.62% 2.18	5.68	0.24	-2.21	-1.68
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$46.06

0.41%

ROIV

$28.99

1.33%

MRNA

$54.07

1.61%

BNTX

$90.20

0.16%

INSM

$141.15

1.23%

ONC

$288.30

0.99%